51 results
8-K
EX-99.1
BTAX
Biostax Corp.
13 Apr 17
Entry into a Material Definitive Agreement
12:00am
proprietary formulation of lower-dose naltrexone, today announced, that has further strengthened its balance sheet by settling an outstanding long-term debt … . As a result, the Company has settled the majority of its outstanding convertible long-term debt, putting the Company on firm financial ground
8-K
EX-99.1
BTAX
Biostax Corp.
5 May 20
Departure of Directors or Certain Officers
5:19pm
that Dr. Cliff Selsky, a long term Director, has resigned from the Immune Board of Directors to focus on his medical practice during the COVID-19
8-K
BTAX
Biostax Corp.
5 May 20
Departure of Directors or Certain Officers
5:19pm
a strategy for long term viability of the Company to benefit its shareholders.
Director Clifford A. Selsky MD PhD has been unable to participate in recent
8-K
EX-99.1
BTAX
Biostax Corp.
21 Apr 16
Immune Therapeutics signs Binding Letter of Intent to Acquire Chinese CAR-T Technology and Clinical Data
12:00am
diseases. This is the beginning of a long-term strategic partnership between IMUN and STCC. Together, we will expeditiously continue our quest
8-K
6b8dy5p 7qwo
20 Jan 15
Immune Therapeutics, Inc. Announces Appointment of New Director and Acceptance of Election by Director
12:00am
10-12G/A
EX-10.13
vo7m1pz sy0
25 Sep 13
Registration of securities (amended)
12:00am
10-12G
hmhn27zeaaarsic3jb
22 Apr 13
Registration of securities
12:00am
10-12G/A
2dic3ihzdt
7 Jun 13
Registration of securities (amended)
12:00am
10-12G/A
tp0w7ii
18 Jul 13
Registration of securities (amended)
12:00am
10-12G/A
ts1h s64camz1
23 Aug 13
Registration of securities (amended)
12:00am
10-Q
m964ntq
15 May 13
Quarterly report
12:00am
10-12G/A
g9hvyq3tlxzehu7 n3q7
25 Sep 13
Registration of securities (amended)
12:00am
10-12G/A
z4ddt
23 Jan 14
Registration of securities (amended)
12:00am
10-12G/A
3vjze0
11 Oct 13
Registration of securities (amended)
12:00am
10-12G/A
n9j1ffb up
7 Feb 14
Registration of securities (amended)
12:00am
10-12G/A
nylp3 92t6
21 Nov 13
Registration of securities (amended)
12:00am